Recent News

• 02.24.2026 - Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
• 02.16.2026 - Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
• 02.06.2026 - CMS Maintains NOPAIN Act Eligibility for ON‑Q* and ambIT* Infusion Pumps; Adds Game Ready* in 2026
• 01.20.2026 - A Clear Vision for Avanos: Purpose, Focus and Growth in 2026 and Beyond
• 12.10.2025 - From Strategy to the CFO Seat: Lessons from My Journey
• 11.11.2025 - With Thanks and Gratitude on Veterans Day
• 11.06.2025 - Doing the Right Things the Right Way: Finding Our “Fast Car” Through Collaboration
• 11.05.2025 - Avanos Medical, Inc. Announces Third Quarter 2025 Results

Recent Filings

• 02.24.2026 - EX-99.1 EX-99.1
• 02.24.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.24.2026 - 8-K Current report
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.21.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.13.2026 - EX-99.1 EX-99.1
• 01.13.2026 - 8-K Current report
• 12.05.2025 - 8-K/A Current report
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities